UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000045198
Receipt No. R000050672
Scientific Title To investigate the effect of a self-management tool for patients with obstructive sleep apnea initiating continuous positive airway pressure (CPAP) treatment
Date of disclosure of the study information 2021/09/01
Last modified on 2021/09/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title To investigate the effect of a self-management tool for patients with obstructive sleep apnea initiating continuous positive airway pressure (CPAP) treatment
Acronym To investigate the effect of self-management tool for initiating CPAP treatment
Scientific Title To investigate the effect of a self-management tool for patients with obstructive sleep apnea initiating continuous positive airway pressure (CPAP) treatment
Scientific Title:Acronym To investigate the effect of self-management tool for initiating CPAP treatment
Region
Japan

Condition
Condition Obstructive Sleep Apnea
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to examine whether myAir(TM), a self-management app, leads to behavioral changes and improves CPAP adherence in patients with obstructive sleep apnea who initiate CPAP treatment.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The percentage of CPAP usage of 4 hours or more should be 70% or more within three months.
Key secondary outcomes Percentage of days used
Average usage time
Mask leakage
Sleep Questionnaire
Time to discontinuation of CPAP
and so on

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom
Interventions/Control_1 App-based coaching
Interventions/Control_2 No use of app-based coaching
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients who meet the indications for CPAP therapy in Japan according to the past sleep study.
Patients who plan to initiate CPAP therapy for obstructive sleep apnea.
and so on
Key exclusion criteria Patients who are unable to access the website or receive e-mails using a computer or smart phone.
Patients who are unable to make outpatient visits or telephone revisits at the prescribed intervals for 6 months.
and so on
Target sample size 160

Research contact person
Name of lead principal investigator
1st name Yasuhiro
Middle name
Last name Tomita
Organization Toranomon Hospital
Division name Sleep Center
Zip code 105-8470
Address Toranomon 2-2-2, Minato-ku, Tokyo
TEL 03-3588-1111
Email ytomita.tmy@gmail.com

Public contact
Name of contact person
1st name Yasuhiro
Middle name
Last name Tomita
Organization Toranomon Hospital
Division name Sleep Center
Zip code 105-8470
Address Toranomon 2-2-2, Minato-ku, Tokyo
TEL 03-3588-1111
Homepage URL
Email ytomita.tmy@gmail.com

Sponsor
Institute Toranomon Hospital
Institute
Department

Funding Source
Organization ResMed Pty Ltd
Organization
Division
Category of Funding Organization Outside Japan
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The ethics committee of Toranomon Hospital
Address Toranomon 2-2-2, Minato-ku, Tokyo
Tel 03-3588-1111
Email chiken-jim@toranomon.gr.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1 The ethics committee of Toranomon Hospital
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 虎の門病院(東京都)

Other administrative information
Date of disclosure of the study information
2021 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 08 Month 23 Day
Date of IRB
2021 Year 09 Month 06 Day
Anticipated trial start date
2021 Year 10 Month 01 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2025 Year 12 Month 31 Day

Other
Other related information

Management information
Registered date
2021 Year 08 Month 19 Day
Last modified on
2021 Year 09 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050672